Delivery Order SPE2DB22D1041-SPE2DB24FUDP5

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $1,507.65, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4564829330 ! YUVAFEM 10 MCG VAGINAL INSERT 8S medical supplies. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for supplying a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,554.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S. The award is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of YUVAFEM 10 MCG vaginal inserts. The $1,160.93 firm-fixed-price contract has an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,536.66 firm fixed-price delivery order contract covers the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized medication. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,481.15 contract is to provide the pharmaceutical product YUVAFEM 10 MCG VAGINAL INSERT 18S. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA. The IDC allows Amerisourcebergen to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,087.68 firm fixed-price delivery order is for the supply of YUVAFEM 10 MCG vaginal inserts. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,239.19 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YUVAFEM 10 MCG vaginal inserts. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to military treatment...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $7,368.84 firm fixed-price delivery order is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of YUVAFEM 10 MCG vaginal inserts. The contract award has a ceiling value of $4,563.32 and an ultimate completion date of August 23, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.13, is for the delivery of 4567268628 YUVAFEM 10 MCG VAGINAL INSERT 18S medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDP5
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $2,199.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply YUVAFEM 10 MCG VAGINAL INSERT 18S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 5, 2024.

Generated 12/4/24, 10:09 AM